Arterial Hypertension
Conditions
Keywords
Arterial hypertension
Brief summary
This study will describe the factors influencing the physician in face of elevated blood pressure in already treated patients
Interventions
Patients under daily life treatment receiving Pritor according to local drug information.
Sponsors
International Clinical Trials Association
Bayer
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Men or women over 18 * Hypertensive patients * Uncontrolled hypertension (blood pressure \>/=140/90 mmHg on the day of consultation or \>/=130/80 mmHg in diabetic patients or in patients suffering from kidney failure, or in elderly patients with a systolic blood pressure \>/=150 mmHg (in the absence of orthostatic hypotension) * Patients treated with a combination, fixed or not, of Renin-Angiotensin System Blocker (RASB) + Hydrochlorothiazide (HCTZ) * Patients examined in common medical care practice, whatever the reason for consultation * Patients informed of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of patients, according to the level of cardiovascular risk, who, at the end of the visit:- do not present any modification of hypertension treatment (therapeutic inertia) - present a change in the hypertension therapeutic | on day 1 |
Secondary
| Measure | Time frame |
|---|---|
| Analyses of the factors that had an impact on the therapeutic decision | on day 1 |
Countries
France
Outcome results
None listed